Caris Life SciencesCAI
那斯達克 · USD
25.56
-0.71
(-2.70%)
盤中 01/21 10:56 (UTC+8)
01/21 10:56 (UTC+8)
Caris Life SciencesCAI
25.56
-0.71
(-2.70%)
財務數據
損益表
- 0.91
- 0.82
- 0.81
- 0.86
- 1.01
- 0.81
- 1.00
- 1.21
- 1.81
- 2.17
- 11.79
- -10.50
- -0.94
- 6.06
- 17.66
- -
- 24.01
- -
- 50.02
- 19.53
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q2 | 2024/Q1 | 2021/Q3 | 2021/Q2 | 2021/Q1 | 2020/Q4 | 2020/Q3 | |
營業收入淨額 | 216,833 | 181,398 | 120,915 | 100,049 | 80,677 | 100,827 | 85,695 | 80,800 | 81,567 | 91,137 |
營業成本 | 69,327 | 67,713 | 63,852 | 62,495 | 54,563 | - | - | - | - | - |
營業毛利 | 147,506 | 113,685 | 57,063 | 37,554 | 26,114 | 100,827 | 85,695 | 80,800 | 81,567 | 91,137 |
營業費用 | 114,864 | 131,674 | 115,014 | 104,565 | 118,339 | 47,576 | 41,882 | 38,780 | 39,226 | 69,285 |
研發費用 | 21,624 | 25,047 | 23,066 | 24,787 | 34,376 | - | - | - | - | - |
推銷及管理費用 | 93,240 | 106,627 | 91,948 | 79,778 | 83,963 | 14,898 | 12,612 | 10,229 | 11,435 | 17,037 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 19,724 |
其他營業費用 | - | - | - | - | - | 32,678 | 29,270 | 28,551 | 27,791 | 32,524 |
營業利益 | 32,642 | -17,989 | -57,951 | -67,011 | -92,225 | 66,443 | 50,839 | 48,763 | 46,691 | 24,868 |
其他收入及費用 | - | - | - | - | - | 13,040 | 7,100 | 6,333 | 2,547 | 113 |
利息費用 | 13,507 | 19,208 | 12,782 | 13,674 | 9,290 | 11,458 | 11,114 | 11,172 | 12,169 | 20,628 |
稅前純益 | 24,325 | -71,790 | -102,581 | -66,186 | -111,028 | 54,833 | 39,799 | 37,181 | 32,719 | 1,337 |
所得稅 | 0 | 0 | 0 | 0 | 0 | 3,678 | 1,856 | 2,504 | -2,000 | -2,697 |
稅後純益 | 24,325 | -71,790 | -102,581 | -66,186 | -111,028 | 51,155 | 37,943 | 35,740 | 14,246 | 15,443 |
基本每股稅後盈餘(元) | 0.09 | -7.97 | -0.40 | -0.35 | -0.53 | 2.82 | 2.07 | 1.94 | 0.68 | 0.75 |
稀釋每股稅後盈餘(元) | 0.08 | -7.97 | -0.40 | -0.35 | -0.53 | 2.79 | 2.05 | 1.91 | 0.67 | 0.75 |
基本平均股數(千股) | 282099.00 | 64918.00 | 254788.00 | 254788.00 | 254788.00 | 17337.00 | 17281.00 | 17271.00 | 17711.00 | 17570.00 |
稀釋平均股數(千股) | 297211.00 | 64918.00 | 254788.00 | 254788.00 | 254788.00 | 17531.00 | 17479.00 | 17518.00 | 17949.00 | 17706.00 |
還原基本每股稅後盈餘(元) | 0.09 | -7.97 | -0.40 | -0.35 | -0.53 | 2.82 | 2.07 | 1.94 | 0.68 | 0.75 |
還原稀釋每股稅後盈餘(元) | 0.08 | -7.97 | -0.40 | -0.35 | -0.53 | 2.79 | 2.05 | 1.91 | 0.67 | 0.75 |
還原基本平均股數(千股) | 282,099 | 64,918 | 254,788 | 254,788 | 254,788 | 17,337 | 17,281 | 17,271 | 17,711 | 17,570 |
還原稀釋平均股數(千股) | 297,211 | 64,918 | 254,788 | 254,788 | 254,788 | 17,531 | 17,479 | 17,518 | 17,949 | 17,706 |
EBITDA(千元) | 42,702 | -46,173 | -82,754 | -40,902 | -84,033 | 99,997 | 81,191 | 78,997 | 55,511 | 70,807 |